PDP1 and angina pectoris: Ranolazine and Dichloroacetate are two other anti-angina agents which act on cardiac metabolism by increasing PDH activity, thus removing the FA-associated negative feedback upon glucose oxidation (Scirica and Morrow, 2007; Scirica et al., 2007; Gutierrez et al., 2015).